What is UroGen Pharma's financing cash flow?

UroGen Pharma (URGN) reported financing cash flow of $65.2M in Q1 2026.

How has UroGen Pharma's financing cash flow changed year-over-year?

UroGen Pharma's financing cash flow increased by 191676.5% year-over-year, from $34K to $65.2M.

What is the long-term trend for UroGen Pharma's financing cash flow?

Over 3 years (2022 to 2025), UroGen Pharma's financing cash flow has grown at a -25.7% compound annual growth rate (CAGR), from $97.21M to $39.92M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

UroGen Pharma URGN Financing Cash Flow

Financing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$1.56B-57.1%

PfizerPFE

-$2.86B+45.4%

Johnson & JohnsonJNJ

$530M-94.9%

Merck & Co.MRK

-$2.98B+48.2%

ImmunityBio, Inc.IBRX

$223.93M+22,903%

Tyra Biosciences, Inc.TYRA

$160.38M+7,233%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's financing cash flow?: UroGen Pharma (URGN) reported financing cash flow of $65.2M in Q1 2026.
How has UroGen Pharma's financing cash flow changed year-over-year?: UroGen Pharma's financing cash flow increased by 191676.5% year-over-year, from $34K to $65.2M.
What is the long-term trend for UroGen Pharma's financing cash flow?: Over 3 years (2022 to 2025), UroGen Pharma's financing cash flow has grown at a -25.7% compound annual growth rate (CAGR), from $97.21M to $39.92M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.